Anzeige
Mehr »
Sonntag, 31.08.2025 - Börsentäglich über 12.000 News
Wie SuperBuzz am Freitag parabolisch durchstartete - und warum das erst der Anfang sein könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Frankfurt
29.08.25 | 17:15
1,410 Euro
+0,71 % +0,010
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,4001,48030.08.
1,4101,46029.08.

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoCMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR VITILIGO AND HIDRADENITIS SUPPURATIVA INDICATION OF INNOVATIVE ...1
19.08.China Medical System H1 Net Profit Rises1
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
19.08.China Medical System Holdings Ltd.: CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers694SHENZHEN, CHINA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- On 18 August, China Medical System Holdings Limited ("CMS" or the "Company") announced its interim results for the six months ended 30 June 2025...
► Artikel lesen
19.08.China Medical System profit up 3.1% in H14
18.08.CMS (00867): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION2
18.08.CMS (00867): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2025-
18.08.CMS (00867): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 AND RESIGNATION OF NON-EXECUTIVE DIRECTOR1
06.08.CMS (00867): NOTICE OF BOARD MEETING1
28.07.China Medical System Holdings Ltd. (867.HK, 8A8.SG)NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China1
28.07.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR THE TREATMENT OF MILD-TO-MODERATE DEMENTIA OF THE ALZHEIMER'S TYPE OF ...1
23.07.China Medical System Holdings Ltd boosts global presence with Singapore Exchange listing4
21.07.China Medical System Holdings Limited: CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets429SINGAPORE, July 21, 2025 - (ACN Newswire) - On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Board of the Singapore...
► Artikel lesen
15.07.China Medical System Holdings Ltd.: A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today450SHENZHEN, CHINA, July 15, 2025 (GLOBE NEWSWIRE) -- On the morning of 15 July 2025, China Medical System Holdings Limited ("CMS" or the "Group") rang the ceremonial bell to mark its official listing...
► Artikel lesen
15.07.CMS (00867): SUCCESSFUL SECONDARY LISTING ON THE SINGAPORE EXCHANGE-
14.07.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR ATOPIC DERMATITIS INDICATION OF INNOVATIVE DRUG HIGHLY SELECTIVE ...-
14.07.CMS (00867): EXPECTED LISTING DATE FOR THE PROPOSED SECONDARY LISTING ON THE SINGAPORE EXCHANGE1
30.06.China Medical System eyes secondary listing on SGX in July1
27.06.CMS (00867): OVERSEAS REGULATORY ANNOUNCEMENT INTRODUCTORY DOCUMENT1
27.06.CMS (00867): UPDATE ON THE PROPOSED SECONDARY LISTING ON THE SINGAPORE EXCHANGE RECEIPT OF ELIGIBILITY-TO-LIST LETTER FROM THE SGX-ST1
25.06.China Medical System Holdings Ltd. Holdings Limited: Proposed Secondary Listing on the Singapore Exchange311SHENZHEN, CHINA, June 25, 2025 (GLOBE NEWSWIRE) -- The board of directors of China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group") announces the proposed...
► Artikel lesen
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1